2Zhou, Y.M. Othus, et al. Pre- and post-transplant quantification of measurable ('minimal') residual disease via muhiparameter flow cytometry in adult acute myeloid leukemia[J].Leukemia,2016,2.2.
3Wang, Y.L. Peng, et al. Clinical value to quantitate hematogones in Chinese childhood acute lymphoblastic leukemia by flow cytometry analysis[J]. International journal of laboratory hematology,2016.
4Swerdlow(2008)WHO classification of umoursoofhaematopoietic and lymphoid tissues, World Health Organization.
5Wang, W.L. Gao, et al. The application of CD73 in minimal residual disease monitoring using flow cytometry in B-cell acute lymphoblastic leukemia [J]. Leukemia & lymphoma, 2015,1-8.
6Wang, L.H. Degheidy, et al. Quantitative Flow Cytometry Measurements in Antibodies Bound per Cell Based on a CD4 Reference[J]. Current protocols in cytometry,2016,75,21-22.
5D Urso V,Collodoro A,Mattioli E,et al.Cytometry and DNA ploidy:clinical uses and molecular perspective in gastric and lung cancer [J].J Cell Physiol,2010,222(3): 532-539.
6Olaru D, Campos L, Flandrin P,et al.Muhiparametric analysts of normal and postchemotherapy bone marrow:implication for the detection of leukemia-associated immunophenotypes [J].Cytometry B Clin Cytom,2008,74(1) : 17-24.
7Nieto WG,Almeida J,Romem A Nieto WG,et al.Increased frequency(12%)of circulating chronic lymphocytic leukemia like B-cell clones in healthy subjects using a highly sen- sitive muhicolor flow cytometry approach [J].Blood,2009,114:33-37.
8Pedreira CE,Costa ES,Almeida J,et al.A probabilistic ap- proach for the evaluation of minimal residual disease by muhiparameter flow cytometry in leukemic B-cell chronic lymphopmlifemtive disorders [J].Cytometry Part A 2008,73A : 1141-1150.
10Nieto WG,Almeida J,Teodosio c,et al.Commentary: Comparison of current flow cytometry methods for monoclonal B cell lymphocytosis detection [J].Cytometry B Clin Cytom.2010,1 (78) : S4-9.
